Model based estimation of the SARS-CoV-2 immunization level in austria and consequences for herd immunity effects
Authors:
Open Access
- 21 February 2022
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-15
Abstract
Several systemic factors indicate that worldwide herd immunity against COVID-19 will probably not be achieved in 2021. On the one hand, vaccination programs are limited by availability of doses and on the other hand, the number of people already infected is still too low to have a disease preventing impact and new emerging variants of the virus seem to partially neglect developed antibodies from previous infections. Nevertheless, by February 2021 after one year of observing high numbers of reported COVID-19 cases in most European countries, we might expect that the immunization level should have an impact on the spread of SARS-CoV-2. Here we present an approach for estimating the immunization of the Austrian population and discuss potential consequences on herd immunity effects. To estimate immunization we use a calibrated agent-based simulation model that reproduces the actual COVID-19 pandemic in Austria. From the resulting synthetic individual-based data we can extract the number of immunized persons. We then extrapolate the progression of the epidemic by varying the obtained level of immunization in simulations of an hypothetical uncontrolled epidemic wave indicating potential effects on the effective reproduction number. We compared our theoretical findings with results derived from a classic differential equation SIR-model. As of February 2021, $$14.7\%$$ of the Austrian population has been affected by a SARS-CoV-2 infection which causes a $$9\%$$ reduction of the effective reproduction number and a $$24.7\%$$ reduction of the prevalence peak compared to a fully susceptible population. This estimation is now recomputed on a regular basis to publish model based analysis of immunization level in Austria also including the fast growing effects of vaccination programs. This provides substantial information for decision makers to evaluate the necessity of non pharmaceutical intervention measures based on the estimated impact of natural and vaccinated immunization.
Keywords
All Related Versions
Funding Information
- Österreichische Forschungsförderungsgesellschaft
- Vienna Science and Technology Fund
- Society for Medical Decision Making
- Medical Scientific Fund of the Mayor of the City of Vienna
This publication has 12 references indexed in Scilit:
- Modeling and Forecasting of COVID-19 Spreading by Delayed Stochastic Differential EquationsAxioms, 2021
- An indirect method to monitor the fraction of people ever infected with COVID-19: An application to the United StatesPLOS ONE, 2021
- Do antibody positive healthcare workers have lower SARS-CoV-2 infection rates than antibody negative healthcare workers? Large multi-centre prospective cohort study (the SIREN study), England: June to November 2020medRxiv, 2021
- Evaluation of undetected cases during the COVID-19 epidemic in AustriaBMC Infectious Diseases, 2021
- Persisting antibody response to SARS-CoV-2 in a local Austrian populationmedRxiv, 2020
- Dynamic multiplex social network models on multiple time scales for simulating contact formation and patterns in epidemic spread2017
- Estimating the herd immunity effect of rotavirus vaccineVaccine, 2015
- Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysisThe Lancet Infectious Diseases, 2015
- A New Framework and Software to Estimate Time-Varying Reproduction Numbers During EpidemicsAmerican Journal of Epidemiology, 2013
- A contribution to the mathematical theory of epidemicsProceedings of the Royal Society of London. Series A, Containing Papers of a Mathematical and Physical Character, 1927